All

Oct 4 2018

Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women

Chen BA, Zhang J, Gundacker HM, Hendrix CW, Hoesley CJ, Salata RA, Dezzutti CS, van der Straten A, Hall WB, Johnson CE, Johnson S, McGowan I, Nel AM, Soto-Torres L, Marzinke MA. Clinical Infectious... More »

May 31 2018

Contraceptive Preference Among Women at Risk of HIV Acquisition in a Preparatory Screening Study for a Phase III Microbicide Trial in South Western Uganda

Kusemererwa S, Abaasa A, Onyango M, Nel AM, Isaacs M, Asiki G. AIDS and Behavior. 2018 May 31, doi: 10.1007/s10461-018-2177-3 [epub ahead of print].  More »

May 29 2018

Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial

Nel A, Martins J, Bekker LG, Ramjee G, Masenga G, Rees H, van Niekerk N. PLOS ONE. 2018 May 29; 13(5): e0196904. More »

Sep 20 2017

Dapivirine Ring: The Case for Action

Women need HIV prevention options they can control. IPM's monthly dapivirine ring is the first discreet, long-acting product designed specifically for women that has been clinically shown to reduce... More »

Sep 5 2017

2017 IPM Annual Report: Women & HIV Prevention: Expanding the Options, Empowering Women

IPM’s 2017 annual report takes a look at promising woman-centered technologies that could expand women's prevention options and help empower them to protect their sexual and reproductive health on... More »

Pages